ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

Agents Not Indicated In Curative Setting.

August 8, 2008

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

NCI’s Weinstein Said He Never Pressured Researcher

November 3, 1995

GM Sends STAR Information To Its Female Employees.

February 23, 2001